JPRN-UMIN000001605已完成1 期
peginterferon alfa-2b and ribavirin plus pitavastatin for chronic hepatitis type C : A pilot study - peginterferon alfa-2b and ribavirin plus pitavastatin for chronic hepatitis type C
Hiroshima liver study group0 个研究点目标入组 50 人开始时间: 2008年12月26日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients receiving shosaiko-to 2)Autoimmune hepatitis 3)History of hypersensitivity to PEG-IFN alpha-2b 4)History of hypersensitivity to biological products such as vaccine 5)Decompenstated liver cirrhosis 6)HCC, malignat tumor 7)With or with a history of severe psychosis such as severe depression, suicidal ideation or attempt, etc. 8)Pregnant or lactating women and women who may be pregnant 9)Judged by investigator not to be appropriate for inclusion in this study
研究者
相似试验
进行中（未招募）
不适用
Peginterferon alfa-2a and Ribavirin Combination Therapy in Patients with HBeAg-negative Chronic HBV Infection - PARC studyEUCTR2004-004736-30-ATErasmus MC122
进行中（未招募）
不适用
Peginterferon alfa-2a and Ribavirin Combination Therapy in Patients with HBeAg-negative Chronic HBV Infection - PARC studychronic HBeAg-negative hepatitis BEUCTR2004-004736-30-DEFoundation of Liver research122
进行中（未招募）
不适用
Treatment with Peg-interferon alfa-2a and ribavirin in patients with hepatitis HCV-related, with or without HIV co-infection, and end stage renal disease on dialysis - NDChonic hepatitis HCV-relatedMedDRA version: 9.1Level: SOCClassification code 10019805MedDRA version: 9.1Level: SOCClassification code 10038359EUCTR2010-023245-30-ITISTITUTO NAZIONALE DELLE MALATTIE INFETTIVE LAZZARO SPALLANZANI
已完成
4 期
Peginterferon-alpha plus ribavirin therapy following twice-daily administration of interferon-beta in patients with genotype 1 and high viral load.patients with HCV genotype 1 and high viral loadJPRN-UMIN000003410Gunma Liver Study Group35
已完成
2 期
A comparison of peginterferon alfa-2a plus ribavirin and peginterferon alfa-2b plus ribavirin for. postmenopausal women. with chronic hepatitis type C : An open-label randomized controlled trial.Chronic hepatitis CJPRN-UMIN000001604Hiroshima liver study group80